BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Banerjee S. Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks. Adv Exp Med Biol 2021. [PMID: 33945128 DOI: 10.1007/5584_2021_634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Bailly C. Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer. Eur J Pharmacol 2022;931:175191. [PMID: 35964660 DOI: 10.1016/j.ejphar.2022.175191] [Reference Citation Analysis]
2 Ketavarapu V, Ravikanth V, Sasikala M, Rao GV, Devi CV, Sripadi P, Bethu MS, Amanchy R, Murthy HVV, Pandol SJ, Reddy DN. Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis. BMC Cancer 2022;22:792. [PMID: 35854233 DOI: 10.1186/s12885-022-09816-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Westermann M, Adomako-bonsu AG, Thiele S, Çiçek SS, Martin H, Maser E. Inhibition of human carbonyl reducing enzymes by plant anthrone and anthraquinone derivatives. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.109823] [Reference Citation Analysis]
4 Bose C, Hindle A, Lee J, Kopel J, Tonk S, Palade PT, Singhal SS, Awasthi S, Singh SP. Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells. Cancers (Basel) 2021;13:6377. [PMID: 34944997 DOI: 10.3390/cancers13246377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Shao X, Wu J, Yu S, Zhou Y, Zhou C. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition. Aging (Albany NY) 2021;13:22298-314. [PMID: 34552036 DOI: 10.18632/aging.203538] [Reference Citation Analysis]